s6y RVL Pharmaceuticals plc EFFECT

RVL Pharmaceuticals plc EFFECT, filed Dec 9, 2021: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 9, 2021 4:00 P.M.
Form: S-3
CIK: 0001739426
Company Name: Osmotica Pharmaceuticals plc
File Number: 333-260529